Showing results (211-220 of 243) with videos related to
Sort By:
Pageof 25
Cancers|November 11, 2022
Prognostic Model for Intracranial Progression after Stereotactic Radiosurgery: A Multicenter Validation StudyDavid J Carpenter, Brahma Natarajan, Muzamil Arshad, et al.International Journal of Radiation Oncology, Biology, Physics|December 14, 2023
Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung Cancer Brain MetastasesEugene J Vaios, Rachel F Shenker, Peter G Hendrickson, et al.Nature Communications|September 29, 2025
Post-resection delivery of a TLR7/8 agonist from a biodegradable scaffold achieves immune-mediated glioblastoma clearance and protection against tumor challenge in miceElizabeth G Graham-Gurysh, Ryan N Woodring, Sean R Simpson, et al.Nature Medicine|August 15, 2018
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.Nature Medicine|January 24, 2019
Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.Neurosurgery|April 16, 2021
Re-evaluating Biopsy for Recurrent Glioblastoma: A Position Statement by the Christopher Davidson Forum InvestigatorsEdjah K Nduom, Melanie Hayden Gephart, Milan G Chheda, et al.Journal of Neurosurgery|April 4, 2025
Intraoperative brain tumor classification via laser-induced fluorescence spectroscopy and machine learningTanner J Zachem, Jacob E Sperber, Sully F Chen, et al.Neuro-Oncology Advances|May 25, 2022
Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastomaJohn F de Groot, Albert H Kim, Sujit Prabhu, et al.The Lancet. Oncology|November 27, 2025
Neurocognitive outcomes in patients with brain metastases: a systematic reviewTarek Bou Dargham, Sebastian F Winter, Kristen Batich, et al.Cancer Discovery|October 1, 2013
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumorsEsra A Akbay, Shohei Koyama, Julian Carretero, et al.Pageof 25